论文部分内容阅读
目的 探讨茵栀黄注射液和促肝细胞生长素等中西药联合人工肝 (血浆置换法 )治疗重型肝炎的疗效、安全性及影响疗效的因素。方法 39例重型肝炎患者在内科治疗基础上给予联合方法治疗 71例次。结果 39例重型肝炎患者经联合治疗后 ,临床症状都得到一定程度的改善 ,肝功能明显好转。总存活率为 6 9 3% (2 7/ 39) ,总不良反应率为 18 3% (13/71) ,患者耐受性好。结论 中西药联合人工肝方法对于抢救重型病毒性肝炎是一种安全、有效的治疗方法
Objective To investigate the curative effect and safety of Yinzhihuang injection and hepatocyte growth-promoting factor, such as traditional Chinese medicine and western medicine combined with artificial liver (plasmapheresis method) in the treatment of severe hepatitis, and the factors influencing curative effect. Methods Thirty-nine patients with severe hepatitis were treated 71 times on the basis of medical treatment. Results After the treatment of 39 cases of severe hepatitis, the clinical symptoms were improved to a certain extent, and the liver function improved obviously. The overall survival rate was 693% (27/39), with a total adverse reaction rate of 18 3% (13/71). Patients were well tolerated. Conclusion Chinese and Western medicine combined with artificial liver method is a safe and effective treatment for the treatment of severe viral hepatitis